The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a bidding war over the drugmaker Metsera. Lilly said Thursday that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback